Comparative analysis of immune infiltrates in head and neck cancers across anatomical sites

BackgroundThe response rate to immune checkpoint inhibitors targeting programmed cell death 1 (PD-1) receptor is 13%–18% for patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC). Detailed understanding of the tumor immune microenvironment (TIME) is crucial in order to...

Full description

Saved in:

Bibliographic Details
Published in:	Journal for immunotherapy of cancer Vol. 12; no. 1; p. e007573
Main Authors:	Muijlwijk, Tara, Nijenhuis, Dennis N L M, Ganzevles, Sonja H, Brink, Arjen, Ke, Changlin, Fass, Joseph N, Rajamanickam, Venkatesh, Leemans, C René, Koguchi, Yoshinobu, Fox, Bernard A, Poell, Jos B, Brakenhoff, Ruud H, van de Ven, Rieneke
Format:	Journal Article
Language:	English
Published:	England BMJ Publishing Group Ltd 11.01.2024 BMJ Publishing Group LTD BMJ Publishing Group
Series:	Original research
Subjects:	Antibodies Basic Tumor Immunology Cancer therapies Carcinogens Cell death Datasets Flow cytometry Genomes Head & neck cancer Head and Neck Neoplasms Human papillomavirus Immune checkpoint inhibitors Immunology Laryngeal cancer Larynx Lymphocytes Lymphocytes, Tumor-Infiltrating Medical prognosis Metastasis Patients Programmed Cell Death 1 Receptor Squamous cell carcinoma T-Lymphocytes Tumor Microenvironment Tumors Tumor Microenvironment Programmed Cell Death 1 Receptor Lymphocytes, Tumor-Infiltrating T-Lymphocytes Head and Neck Neoplasms
ISSN:	2051-1426, 2051-1426
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!